The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:$107.5MM In 35 Days Not Rated 0.0 Email Routing List Email & Route  Print Print
Monday, December 27, 2021

$107.5MM In 35 Days

Reported by Neil Anderson, Managing Editor

A new contrarian fund recently crossed into nine-figure territory in about five weeks.

Earlier this month, Matthew Tuttle, CEO and chief investment officer of Tuttle Capital Management LLC (TCM), confirmed that the Tuttle Capital Short Innovation ETF (SARK on the Nasdaq) reached $107.5 million in AUM as of December 14, just 35 days after it launched on November 9. Per TCM, the fund, an active ETF, crossed the $100-million mark in 24 trading days. (Greenwich, Connecticut-based TCM, across its 12 strategies, had $227 million in total AUM as of December 14.)

The TCM team also reports that SARK is the fifth most actively traded new ETF of 2021, with more than $21.5 million traded on average per day. (And options on SARK started trading on December 1.)

Tuttle serves PM of SARK, while TCM is its investment advisor. SARK's other service providers include: BBD, LLP as independent accounting firm; Citi Fund Services Ohio, Inc. as fund administrator and accountant and Citibank N.A. as custodian; Foreside Fund Services, LLC as distributor; and Thompson Hine LLP as counsel. The fund is effectively a way to bet against a certain high-profile, innovation-focused ETF

Stay ahead of the news ... Sign up for our email alerts now

 Do You Recommend This Story?

Return to Top
 News Archives
2024: Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Add to My Yahoo!
follow us in feedly

©All rights reserved to InvestmentWires, Inc. 1997-2024
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use